QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone

被引：82
|
作者：
Gil, M
Sala, M
Anguera, I
Chapinal, O
Cervantes, M
Guma, JR
Segura, F
机构：
[1] Corporacio Sanitaria Parc Tauli, Hosp Sabadell, Infect Dis Unit, Dept Internal Med, Sabadell, Barcelona, Spain
[2] Corporacio Sanitaria Parc Tauli, Hosp Sabadell, Dept Cardiol, Dept Internal Med, Sabadell, Barcelona, Spain
[3] CAS Drogodependencies Sabadell, Barcelona, Spain
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 08期
关键词：
D O I：
10.1016/S0002-9149(03)00906-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Four patients infected with human immunodeficiency virus receiving antiretroviral treatment and high doses of methadone (>200 mg/day) presented with several syncopal episodes. A significant prolongation of the QTc interval was detected in all of them, and in 3 patients, greater than or equal to1 episode of Torsades de Pointes was recorded. The sequence of events in these cases suggests that high doses of methadone caused QT prolongation and provided the substrate for syncope and Torsades de Pointes. (C) 2003 by Excerpta Medica, Inc.
引用
收藏
页码：995 / 997
页数：3
相关论文
共 50 条
  • [21] Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori, Liat
    Kinori, Michael
    Kogan, Yevgeni
    Swartzon, Michael
    Shalev, Hadas
    Guy, Daniel
    Ferenidou, Fotini
    Mashav, Noa
    Sadeh, Ben
    Atzmony, Lihi
    Kliuk-Ben-Basat, Orit
    Steinvil, Arie
    Justo, Dan
    JOURNAL OF ELECTROCARDIOLOGY, 2009, 42 (04) : 353 - 357
  • [22] QT PROLONGATION AND TORSADES-DE-POINTES AFTER ADMINISTRATION OF ANTIBIOTICS
    BAVOUX, F
    THERAPIE, 1992, 47 (05): : 367 - 369
  • [23] A CASE OF QT PROLONGATION AND TORSADES DE POINTES CAUSED BY IBOGAINE TOXICITY
    Hildyard, Catherine
    Macklin, Philip
    Prendergast, Bernard
    Bashir, Yaver
    JOURNAL OF EMERGENCY MEDICINE, 2016, 50 (02): : E83 - E86
  • [24] GlucoseHyperglycaemia and torsades de pointes with marked QT prolongation: case report
    Reactions Weekly, 2017, 1637 (1) : 106 - 106
  • [25] QT prolongation and torsades de pointes in a patient with heart block and a pacemaker
    Bernstein, Brett S.
    Silver, Eric S.
    Liberman, Leonardo
    CARDIOLOGY IN THE YOUNG, 2016, 26 (01) : 161 - 163
  • [26] Torsades de pointes and QT prolongation due to a combination of loratadine and amiodarone
    Atar, S
    Freedberg, NA
    Antonelli, D
    Rosenfeld, T
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (03): : 785 - 786
  • [27] Voriconazole-induced QT interval prolongation and torsades de pointes
    Aypar, Ebru
    Kendirli, Tanil
    Tutar, Ercan
    Ciftci, Ergin
    Ince, Erdal
    Ileri, Talia
    Atalay, Semra
    PEDIATRICS INTERNATIONAL, 2011, 53 (05) : 761 - 763
  • [28] Escitalopram overdoseAcute QT prolongation and torsades de pointes: case report
    Reactions Weekly, 2014, 1515 (1) : 91 - 91
  • [29] QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine
    Malone, Katie
    Hancox, Jules C.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11
  • [30] QT interval prolongation and the risk of torsades de pointes: essentials for clinicians
    Trinkley, Katy E.
    Page, Robert Lee, II
    Lien, Hoang
    Yamanouye, Kevin
    Tisdale, James E.
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (12) : 1719 - 1726
12345